VIDAS VARICELLA ZOSTER IGG 30217

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2015-08-14 for VIDAS VARICELLA ZOSTER IGG 30217 manufactured by Biomerieux, S.a..

Event Text Entries

[24713061] Device not returned to manufacturer.
Patient Sequence No: 1, Text Type: N, H10


[24713062] On (b)(6) 2015 a customer in (b)(6) reported a false negative and borderline result using the vidas varicella-zoster igg kit (ref. 30217, lot 1003869180, expiration date 04-jan-2016). The customer repeated the borderline result with an alternate microplate method (dynex dsx) and obtained a positive result. The customer also retested the negative vidas varicella igg result with the dynex method; positive result was obtained. There was no reported adverse event related to the patient's state of health. Biomerieux has initiated internal investigation.
Patient Sequence No: 1, Text Type: D, B5


[34112543] Biom? Rieux investigation reproduced the results identified by swiss unilabs customer via testing of the fifteen (15) returned samples with vidas? Varicella-zoster igg (vzg), batches 1003869180 and 1004002070. The sample results were determined equivocal or negative. The issue encountered by the customer is not linked with a specific lot. This issue was previously documented based on the results of a comparison study with two other competitor kits. The study concluded there are differences between the three techniques for lower level samples. A large number of equivocal and negative results were observed with vidas? Varicella-zoster igg test. Results of the study (in particular the ratio of equivocal results) are under consideration for future vzg development. As described in the package insert, there is a large "equivocal zone" associated with the vidas? Varicella-zoster igg assay. Results within the eqivocal zone are not considered false results because there is no change of the serological status. Equivocal results should be repeated with a fresh specimen. If it is impractical to obtain a fresh specimen, the assay is repeated with the original specimen. If the sample repeats as an equivocal, the sample should be tested via different method. Vidas? Varicella-zoster igg assay only detects igg and is intended as an aid in the determination of immunological experience with varicella-zoster virus. It's primary use is for vaccination follow-up and is not recommended to isolate igg serology results for the diagnosis of varicella-zoster virus (vzv) infection. As recommended in the package insert, if a definitive determination of vzv immunity is required, patients with negative results should be retested by a more sensitive assay. The investigation determined the vidas? Varicella-zoster igg assay is performing within development specifications in accordance with the defined negative/equivocal/positive zones.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002769706-2015-00069
MDR Report Key5004773
Date Received2015-08-14
Date of Report2015-07-24
Date Mfgr Received2015-07-24
Date Added to Maude2015-08-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. RYAN LEMELLE
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityHAZELWOOD MO 63042
Manufacturer CountryUS
Manufacturer Postal63042
Manufacturer Phone3147318582
Manufacturer G1BIOMERIEUX, INC
Manufacturer Street100 RODOLPHE STREET
Manufacturer CityDURHAM NC 27712
Manufacturer CountryUS
Manufacturer Postal Code27712
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVIDAS VARICELLA ZOSTER IGG
Generic NameVIDAS VARICELLA IGG ASSAY
Product CodeLFY
Date Received2015-08-14
Catalog Number30217
Lot Number1003869180
Device Expiration Date2016-01-04
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOMERIEUX, S.A.
Manufacturer AddressCHEMIN DE L ORME MARCY L ETOILE, RHONE 69280 FR 69280


Patients

Patient NumberTreatmentOutcomeDate
10 2015-08-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.